Reports - Single-use Bioreactors Market
Biotechnology and Life SciencesSingle-use Bioreactors Market
Single-use Bioreactors Market Growth and Trends | Insights & Forecast 2025-2035 by Product (Single-use Bioreactor Systems, Single-use Media Bags, Single-use Filtration Assemblies, Other Products (Single-use vessels, tubing and connectors, samplers, and probes/sensor, and others)), by Type (Stirred-tank SUBs, Wave-induced SUBs, Bubble-column SUBs, Other SUBs (Hybrid bioreactors and SUBs with vertically perforated discs)), by Type of Cell (Mammalian Cells, Bacterial Cells, Yeast Cells, Other Cells (Insect and plant cells)), by Molecule Type (Monoclonal Antibodies, Vaccines, Gene-modified cells, Stem Cells), by Application (Research and Development (R&D), Process Development, Bioproduction), by End User (Pharmaceutical & Biopharmaceutical Companies, CROs & CMOs, Academic & Research Institutes), by Region (North America, Europe, Asia Pacific, Latin America and Middle East & Africa
Industry Leaders Trust Us For Actionable Intelligence
Table of Contents
Chapter 1 Executive Dashboard
1. Strategic Imperatives
Chapter 2 Premium Insights
1. Top 3 Trends to Watch
2. Demand and Supply Trends
3. Top 3 Strategies Followed by Major Players
4. Top 3 Predictions by Vantage Market Research
5. Top Investment Pockets
6. Insights from Primary Respondents
Chapter 3 Global Single-use Bioreactors Market - Segment Analysis
1. Overview
2. Global Single-use Bioreactors Market, 2021 - 2035 (USD Million)
3. Global Single-use Bioreactors Market - by Product
3.1. By Single-use Bioreactor Systems
3.2. By Single-use Media Bags
3.3. By Single-use Filtration Assemblies
3.4. By Other Products (Single-use vessels, tubing and connectors, samplers, and probes/sensor, and others)
4. Global Single-use Bioreactors Market - by Type
4.1. By Stirred-tank SUBs
4.2. By Wave-induced SUBs
4.3. By Bubble-column SUBs
4.4. By Other SUBs (Hybrid bioreactors and SUBs with vertically perforated discs)
5. Global Single-use Bioreactors Market - by Type of Cell
5.1. By Mammalian Cells
5.2. By Bacterial Cells
5.3. By Yeast Cells
5.4. By Other Cells (Insect and plant cells)
6. Global Single-use Bioreactors Market - by Molecule Type
6.1. By Monoclonal Antibodies
6.2. By Vaccines
6.3. By Gene-modified cells
6.4. By Stem Cells
6.5. By Other Molecules (Recombinant proteins including growth factors & interferons, antisense, RNA interference and others)
7. Global Single-use Bioreactors Market - by Application
7.1. By Research and Development (R&D)
7.2. By Process Development
7.3. By Bioproduction
8. Global Single-use Bioreactors Market - by End User
8.1. By Pharmaceutical & Biopharmaceutical Companies
8.2. By CROs & CMOs
8.3. By Academic & Research Institutes
9. Global Single-use Bioreactors Market - by region
9.1. North America
9.2. Europe
9.3. Asia Pacific
9.4. Latin America
9.5. Middle East & Africa
10. Market comparative analysis
Chapter 4 North America Single-use Bioreactors Market - Segment Analysis
1. Overview
2. North America Single-use Bioreactors Market, 2021 - 2035 (USD Million)
3. North America Single-use Bioreactors Market - by Product
3.1. By Single-use Bioreactor Systems
3.2. By Single-use Media Bags
3.3. By Single-use Filtration Assemblies
3.4. By Other Products (Single-use vessels, tubing and connectors, samplers, and probes/sensor, and others)
4. North America Single-use Bioreactors Market - by Type
4.1. By Stirred-tank SUBs
4.2. By Wave-induced SUBs
4.3. By Bubble-column SUBs
4.4. By Other SUBs (Hybrid bioreactors and SUBs with vertically perforated discs)
5. North America Single-use Bioreactors Market - by Type of Cell
5.1. By Mammalian Cells
5.2. By Bacterial Cells
5.3. By Yeast Cells
5.4. By Other Cells (Insect and plant cells)
6. North America Single-use Bioreactors Market - by Molecule Type
6.1. By Monoclonal Antibodies
6.2. By Vaccines
6.3. By Gene-modified cells
6.4. By Stem Cells
6.5. By Other Molecules (Recombinant proteins including growth factors & interferons, antisense, RNA interference and others)
7. North America Single-use Bioreactors Market - by Application
7.1. By Research and Development (R&D)
7.2. By Process Development
7.3. By Bioproduction
8. North America Single-use Bioreactors Market - by End User
8.1. By Pharmaceutical & Biopharmaceutical Companies
8.2. By CROs & CMOs
8.3. By Academic & Research Institutes
Chapter 5 Europe Single-use Bioreactors Market - Segment Analysis
1. Overview
2. Europe Single-use Bioreactors Market, 2021 - 2035 (USD Million)
3. Europe Single-use Bioreactors Market - by Product
3.1. By Single-use Bioreactor Systems
3.2. By Single-use Media Bags
3.3. By Single-use Filtration Assemblies
3.4. By Other Products (Single-use vessels, tubing and connectors, samplers, and probes/sensor, and others)
4. Europe Single-use Bioreactors Market - by Type
4.1. By Stirred-tank SUBs
4.2. By Wave-induced SUBs
4.3. By Bubble-column SUBs
4.4. By Other SUBs (Hybrid bioreactors and SUBs with vertically perforated discs)
5. Europe Single-use Bioreactors Market - by Type of Cell
5.1. By Mammalian Cells
5.2. By Bacterial Cells
5.3. By Yeast Cells
5.4. By Other Cells (Insect and plant cells)
6. Europe Single-use Bioreactors Market - by Molecule Type
6.1. By Monoclonal Antibodies
6.2. By Vaccines
6.3. By Gene-modified cells
6.4. By Stem Cells
6.5. By Other Molecules (Recombinant proteins including growth factors & interferons, antisense, RNA interference and others)
7. Europe Single-use Bioreactors Market - by Application
7.1. By Research and Development (R&D)
7.2. By Process Development
7.3. By Bioproduction
8. Europe Single-use Bioreactors Market - by End User
8.1. By Pharmaceutical & Biopharmaceutical Companies
8.2. By CROs & CMOs
8.3. By Academic & Research Institutes
Chapter 6 Asia Pacific Single-use Bioreactors Market - Segment Analysis
1. Overview
2. Asia Pacific Single-use Bioreactors Market, 2021 - 2035 (USD Million)
3. Asia Pacific Single-use Bioreactors Market - by Product
3.1. By Single-use Bioreactor Systems
3.2. By Single-use Media Bags
3.3. By Single-use Filtration Assemblies
3.4. By Other Products (Single-use vessels, tubing and connectors, samplers, and probes/sensor, and others)
4. Asia Pacific Single-use Bioreactors Market - by Type
4.1. By Stirred-tank SUBs
4.2. By Wave-induced SUBs
4.3. By Bubble-column SUBs
4.4. By Other SUBs (Hybrid bioreactors and SUBs with vertically perforated discs)
5. Asia Pacific Single-use Bioreactors Market - by Type of Cell
5.1. By Mammalian Cells
5.2. By Bacterial Cells
5.3. By Yeast Cells
5.4. By Other Cells (Insect and plant cells)
6. Asia Pacific Single-use Bioreactors Market - by Molecule Type
6.1. By Monoclonal Antibodies
6.2. By Vaccines
6.3. By Gene-modified cells
6.4. By Stem Cells
6.5. By Other Molecules (Recombinant proteins including growth factors & interferons, antisense, RNA interference and others)
7. Asia Pacific Single-use Bioreactors Market - by Application
7.1. By Research and Development (R&D)
7.2. By Process Development
7.3. By Bioproduction
8. Asia Pacific Single-use Bioreactors Market - by End User
8.1. By Pharmaceutical & Biopharmaceutical Companies
8.2. By CROs & CMOs
8.3. By Academic & Research Institutes
Chapter 7 Latin America Single-use Bioreactors Market - Segment Analysis
1. Overview
2. Latin America Single-use Bioreactors Market, 2021 - 2035 (USD Million)
3. Latin America Single-use Bioreactors Market - by Product
3.1. By Single-use Bioreactor Systems
3.2. By Single-use Media Bags
3.3. By Single-use Filtration Assemblies
3.4. By Other Products (Single-use vessels, tubing and connectors, samplers, and probes/sensor, and others)
4. Latin America Single-use Bioreactors Market - by Type
4.1. By Stirred-tank SUBs
4.2. By Wave-induced SUBs
4.3. By Bubble-column SUBs
4.4. By Other SUBs (Hybrid bioreactors and SUBs with vertically perforated discs)
5. Latin America Single-use Bioreactors Market - by Type of Cell
5.1. By Mammalian Cells
5.2. By Bacterial Cells
5.3. By Yeast Cells
5.4. By Other Cells (Insect and plant cells)
6. Latin America Single-use Bioreactors Market - by Molecule Type
6.1. By Monoclonal Antibodies
6.2. By Vaccines
6.3. By Gene-modified cells
6.4. By Stem Cells
6.5. By Other Molecules (Recombinant proteins including growth factors & interferons, antisense, RNA interference and others)
7. Latin America Single-use Bioreactors Market - by Application
7.1. By Research and Development (R&D)
7.2. By Process Development
7.3. By Bioproduction
8. Latin America Single-use Bioreactors Market - by End User
8.1. By Pharmaceutical & Biopharmaceutical Companies
8.2. By CROs & CMOs
8.3. By Academic & Research Institutes
Chapter 8 Middle East & Africa Single-use Bioreactors Market - Segment Analysis
1. Overview
2. Middle East & Africa Single-use Bioreactors Market, 2021 - 2035 (USD Million)
3. Middle East & Africa Single-use Bioreactors Market - by Product
3.1. By Single-use Bioreactor Systems
3.2. By Single-use Media Bags
3.3. By Single-use Filtration Assemblies
3.4. By Other Products (Single-use vessels, tubing and connectors, samplers, and probes/sensor, and others)
4. Middle East & Africa Single-use Bioreactors Market - by Type
4.1. By Stirred-tank SUBs
4.2. By Wave-induced SUBs
4.3. By Bubble-column SUBs
4.4. By Other SUBs (Hybrid bioreactors and SUBs with vertically perforated discs)
5. Middle East & Africa Single-use Bioreactors Market - by Type of Cell
5.1. By Mammalian Cells
5.2. By Bacterial Cells
5.3. By Yeast Cells
5.4. By Other Cells (Insect and plant cells)
6. Middle East & Africa Single-use Bioreactors Market - by Molecule Type
6.1. By Monoclonal Antibodies
6.2. By Vaccines
6.3. By Gene-modified cells
6.4. By Stem Cells
6.5. By Other Molecules (Recombinant proteins including growth factors & interferons, antisense, RNA interference and others)
7. Middle East & Africa Single-use Bioreactors Market - by Application
7.1. By Research and Development (R&D)
7.2. By Process Development
7.3. By Bioproduction
8. Middle East & Africa Single-use Bioreactors Market - by End User
8.1. By Pharmaceutical & Biopharmaceutical Companies
8.2. By CROs & CMOs
8.3. By Academic & Research Institutes
Chapter 9 Key Market Dynamics
1. Introduction
2. Market Drivers
3. Market Restraints
4. Market Opportunities
5. Porter's Five Forces Analysis
6. PEST Analysis
7. Regulatory Landscape
8. Technology Landscape
9. Regional Market Trends
Chapter 10 COVID 19 Impact Analysis
1. Key strategies undertaken by companies to tackle COVID-19
2. Short term dynamics
3. Long term dynamics
Chapter 11 Marketing Strategy Analysis
1. Marketing Channel
2. Direct Marketing
3. Indirect Marketing
4. Marketing Channel Development Trends
Chapter 12 Competitive Landscape
1. Competition Matrix - 2021
2. Company Market Share Analysis - 2021
3. Key Company Activities, 2018 - 2021
4. Strategic Developments - Heat Map Analysis
5. Company Offering Evaluation
6. Company Regional Presence Evaluation
Chapter 13 Company Profiles
1. Sartorius Stedim Biotech (France)
2. Thermo Fisher Scientific (US)
3. Danaher Corporation (US)
4. Merck KGaA
(Germany)
5. Getinge AB (Sweden)
6. Eppendorf AG (Germany)
7. CESCO Bioengineering (US)
8. Cellexus (US)
9. PBS Biotech Inc. (US)
10. Distek Inc. (US)
11. ABEC (US)
12. Able Corporation & Biott Corporation (Japan)
13. G&G Technologies Inc. (US)
14. Solida Biotech GmBH (Germany)
15. Satake Chemical Equipment Mfg. Ltd. (Japan)
16. Stobbe Pharma GmBH (Germany)
17. Celltainer Biotech BV (Netherlands)
18. Meissner Filtration Products Inc. (US)
19. bbi-biotech GmBH (Germany)
20. ENDEL ENGIE (France)
21. OmniBRx biotechnologies (India)
22. New Horizon Biotechnology Inc. (US)
23. GPC Bio (US)
24. Cell culture company (US)
25. and Aptus bioreactors (US)
Chapter 14 Key Primary Respondents - VERBATIM
Chapter 15 Discussion Guide
Chapter 16 Customization Offered
Chapter 17 Annexure
Chapter 18 List of Figures
Chapter 19 List of Tables
Chapter 20 List of Abbreviations
FAQ‘s
Related Reports
Contact
Toll Free Number+1 (877) 462-2282
© 2025 Vantage Market Research. All right reserved
Secured By